Practical use of osimertinib in Japanese patients with EGFR T790M mutation positive advanced non-small-cell lung cancer

被引：0
|
作者：
Kotake, M. [1 ]
Murakami, H. [1 ]
Naito, T. [1 ]
Takahashi, T. [1 ]
Kenmotsu, H. [1 ]
Ono, A. [1 ]
Wakuda, K. [1 ]
Nakashima, K. [1 ]
Omori, S. [1 ]
机构：
[1] Shizuoka Canc Ctr, Thorac Oncol, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
456P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer
    de Marinis, Filippo
    Wu, Yi-Long
    de Castro Jr, Gilberto
    Chang, Gee-Chen
    Chen, Yuh-Min
    Cho, Byoung Chul
    Freitas, Helano C.
    Jiang, Liyan
    Kim, Sang-We
    Martin, Claudio
    Metro, Giulio
    Provencio, Mariano
    Vansteenkiste, Johan
    Vicente, David
    Zhou, Qing
    Miranda, Miguel F.
    Bakker, Nicolaas A.
    Rigas, James R.
    Cheema, Parneet K.
    FUTURE ONCOLOGY, 2019, 15 (26) : 3003 - 3014
  • [22] Real-Life Data of Osimertinib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
    Alfaro Autor, C.
    Romero, A.
    Calvo De Juan, V.
    Franco, F.
    Sanchez Romero, E.
    Ortiz Cortes, N.
    Sanz Moreno, S.
    Rodriguez Festa, A.
    Serna Blasco, R.
    Barquin Del Romo, M.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1036 - S1036
  • [23] Differential efficacy of Osimertinib in EGFR T790M positive non-small cell lung cancer by metastatic site
    Uematsu, Shinya
    ANNALS OF ONCOLOGY, 2019, 30 : 109 - 109
  • [24] Detection of EGFR T790M mutation in non-small-cell lung cancer patients using colony hybridization assay
    Fujita, Yoshihiko
    Suda, Kenichi
    Kimura, Hideharu
    Matsumoto, Kazuko
    Arao, Tokuzo
    Nagai, Tomoyuki
    Hayashi, Hidetoshi
    Furuta, Kazuyuki
    Kato, Hiroaki
    Saijo, Nagahiro
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    Nishio, Kazuto
    CANCER RESEARCH, 2012, 72
  • [25] Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Peng, Da
    Shan, Dongfeng
    Dai, Chengcheng
    Li, Jie
    Wang, Zifan
    Huang, Ziyi
    Peng, Rui
    Zhao, Peng
    Ma, Xuezhen
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2033 - 2039
  • [26] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Kazuhisa Nakashima
    Yuichi Ozawa
    Haruko Daga
    Hisao Imai
    Motohiro Tamiya
    Takaaki Tokito
    Takahisa Kawamura
    Hiroaki Akamatsu
    Yuko Tsuboguchi
    Toshiaki Takahashi
    Nobuyuki Yamamoto
    Keita Mori
    Haruyasu Murakami
    Investigational New Drugs, 2020, 38 : 1854 - 1861
  • [27] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Nakashima, Kazuhisa
    Ozawa, Yuichi
    Daga, Haruko
    Imai, Hisao
    Tamiya, Motohiro
    Tokito, Takaaki
    Kawamura, Takahisa
    Akamatsu, Hiroaki
    Tsuboguchi, Yuko
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Mori, Keita
    Murakami, Haruyasu
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) : 1854 - 1861
  • [28] EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients
    Zheng, Qiufan
    Hong, Shaodong
    Huang, Yan
    Zhao, Hongyun
    Yang, Yunpeng
    Hou, Xue
    Zhao, Yuanyuan
    Ma, Yuxiang
    Zhou, Ting
    Zhang, Yaxiong
    Fang, Wenfeng
    Zhang, Li
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 9 (01):
  • [29] Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
    Yamane, Hiromichi
    Ochi, Nobuaki
    Yasugi, Masayuki
    Tabayashi, Takayuki
    Yamagishi, Tomoko
    Monobe, Yasumasa
    Hisamoto, Akiko
    Kiura, Katsuyuki
    Takigawa, Nagio
    ONCOTARGETS AND THERAPY, 2013, 6 : 155 - 160
  • [30] Osimertinib in advanced EGFR T790M-positive non-small-cell lung cancer: the clinical impact of AURA3
    Pirker, Robert
    Buder, Anna
    Filipits, Martin
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S265 - S269
12345